Candel Therapeutics Non Current Assets Total Over Time

CADL Stock  USD 5.14  0.24  4.90%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Candel Therapeutics Performance and Candel Therapeutics Correlation.
For more information on how to buy Candel Stock please use our How to buy in Candel Stock guide.
  
The value of Non Current Assets Total is estimated to slide to about 4 M.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Candel Therapeutics. If investors know Candel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Candel Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.73)
Revenue Per Share
0.001
Return On Assets
(0.52)
Return On Equity
(4.81)
The market value of Candel Therapeutics is measured differently than its book value, which is the value of Candel that is recorded on the company's balance sheet. Investors also form their own opinion of Candel Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Candel Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Candel Therapeutics' market value can be influenced by many factors that don't directly affect Candel Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Candel Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Candel Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Candel Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Non Current Assets Total Analysis

Compare Candel Therapeutics and related stocks such as Aerovate Therapeutics, Adagene, and Acrivon Therapeutics, Non Current Assets Total Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On EquityOperating Cycle
Cash Conversion Cycle
201020112012201320142015201620172018201920202021202220232024
AVTE0.00.00.00.00.00.00.00.00.00.039 KM3.8 M3.2 M1.8 M
ADAG2.6 M2.6 M2.6 M2.6 M2.6 M2.6 M2.6 M2.6 M2.6 MM5.2 M3.6 M3.1 M2.3 M3.4 M
ACRV466 K466 K466 K466 K466 K466 K466 K466 K466 K466 K466 K6.2 M53.5 M8.6 M8.1 M
RZLT288.4 K288.4 K288.4 K1.1 M5.1 M6.4 M5.7 M495.1 K108 K447 K616 K316 K18.8 M4.1 MM
ANTX0.00.00.00.00.00.00.00.00.00.00.05.2 M3.9 M28.2 M29.6 M
MOLN2.3 M2.3 M2.3 M2.3 M2.1 M2.5 M2.5 M1.9 M1.8 MM9.7 M8.5 M7.5 M5.9 MM
MLYS20 K20 K20 K20 K20 K20 K20 K20 K20 K20 K20 KK4.3 M2.5 M1.9 M
PHVS0.00.00.00.00.00.00.00.00.012.9 K147.8 K523.4 K886.2 K843.1 K885.3 K
PEPG419 K419 K419 K419 K419 K419 K419 K419 K419 K419 K323 K3.7 M31.4 M30.4 M31.9 M
PMVP1.2 M1.2 M1.2 M1.2 M1.2 M1.2 M1.2 M1.2 M1.2 M940 K770 K30.3 M23.3 M44.7 M47 M
ACXP0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
MNPR800.4 K800.4 K800.4 K800.4 K800.4 K800.4 K800.4 K800 K0.0122.4 K68.9 K0.061.2 K12.6 K12 K
INDP7.5 M7.5 M7.5 M7.5 M7.5 M7.5 M7.5 M7.5 M7.5 M7.5 M45.8 K189.4 K819.6 K928.7 K1.5 M
TPST849 K849 K849 K2.5 M3.7 M8.8 M6.1 M4.1 M652 K3.8 MM4.3 M13.1 M11.2 M5.7 M
FBRXMMMMMM2.9 M1.4 M5.3 M150.6 K1.3 M786 K486 K653 K620.4 K
OKYO9.6 M24.7 M30.6 M35 M27.3 M26.8 M23.7 M1.1 K1.1 K30.7 K104.6 K5.2 K7.2 K3.4 K3.2 K
ANEB0.00.00.00.00.00.00.00.00.00.01.7 MM0.0565.1 K522.2 K
CINGW4.3 M4.3 M4.3 M4.3 M4.3 M4.3 M4.3 M4.3 M4.3 M4.3 MMM3.5 M3.1 MM

Candel Therapeutics and related stocks such as Aerovate Therapeutics, Adagene, and Acrivon Therapeutics, Non Current Assets Total description

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.

My Equities

My Current Equities and Potential Positions

Candel Therapeutics
CADL
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
LocationMassachusetts; U.S.A
ExchangeNASDAQ Exchange
USD 5.14
When determining whether Candel Therapeutics is a strong investment it is important to analyze Candel Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Candel Therapeutics' future performance. For an informed investment choice regarding Candel Stock, refer to the following important reports:
Check out Candel Therapeutics Performance and Candel Therapeutics Correlation.
For more information on how to buy Candel Stock please use our How to buy in Candel Stock guide.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Candel Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Candel Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Candel Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...